Skip Navigation


ToxSci Advance Access originally published online on April 5, 2006
Toxicological Sciences 2006 92(1):126-132; doi:10.1093/toxsci/kfj182
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
92/1/126    most recent
kfj182v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Phalen, R. F.
Right arrow Articles by Nel, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phalen, R. F.
Right arrow Articles by Nel, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Tracheobronchial Particle Dose Considerations for In Vitro Toxicology Studies

Robert F. Phalen*,1, Michael J. Oldham* and Andre E. Nel{dagger}

* Community and Environmental Medicine, School of Medicine, University of California, Irvine, California 92697-1825; and {dagger} Department of Medicine, Division of Immunology and Allergy, University of California, Los Angeles, California 90095

Received January 10, 2006; accepted March 12, 2006

The purpose of this paper is to present a method for estimating particle doses that may be used to reconcile particle deposition doses used in in vitro toxicology studies with in vivo exposure levels. The focus is on the tracheobronchial (TB) tree of heavily exposed individuals. A review of the factors that influence inhaled particle deposition doses in environmental exposures leads to the identification of cases in which greater than average TB tree doses are received. Exercising individuals and those with chronic obstructive pulmonary disease not only inhale increased volumes of air but they also may have uneven ventilation that leads to greater than average particle deposition doses per unit of TB tree surface area. In addition, deposition hot spots, as occur at airway bifurcations, will greatly increase the particle exposures of target cells in the TB tree. Three particle exposure scenarios are proposed, and the average and local doses to the TB epithelium are calculated. When various factors that enhance particle doses (enhancement factors, or EFs) in vivo are considered, substantial particle doses may be justified for in vitro tissue culture studies that use TB target cells, such as epithelial cell cultures. The use of such EFs is intended to improve in vitro dosing with particles. Although the exposure of cells in vitro cannot fully replicate the complexity of in vivo exposures, it is possible to calculate toxicologically relevant doses that may define adverse health effects in potentially sensitive human populations. Local groups of TB cells in high-dose individuals are predicted to receive particle doses that are 3000–25,000 times higher than the doses averaged over the entire TB region.

Key Words: particle deposition; in vitro doses; tracheobronchial tree; high-risk individuals; inhaled particles.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
E. Ghelfi, C. R. Rhoden, G. A. Wellenius, J. Lawrence, and B. Gonzalez-Flecha
Cardiac Oxidative Stress and Electrophysiological Changes in Rats Exposed to Concentrated Ambient Particles are Mediated by TRP-Dependent Pulmonary Reflexes
Toxicol. Sci., April 1, 2008; 102(2): 328 - 336.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. Oberdorster and J. N. Finkelstein
TO THE EDITOR
Toxicol. Sci., December 1, 2006; 94(2): 439 - 439.
[Full Text] [PDF]


Home page
Toxicol SciHome page
R. F. Phalen, M. J. Oldham, and A. E. Nel
TO THE EDITOR
Toxicol. Sci., December 1, 2006; 94(2): 440 - 440.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.